First Time Loading...

WuXi AppTec Co Ltd
SSE:603259

Watchlist Manager
WuXi AppTec Co Ltd Logo
WuXi AppTec Co Ltd
SSE:603259
Watchlist
Price: 55.02 CNY 0.99% Market Closed
Updated: Mar 1, 2024

Intrinsic Value

WuXi AppTec Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. [ Read More ]

The intrinsic value of one WuXi AppTec Co Ltd stock under the Base Case scenario is 135.92 CNY. Compared to the current market price of 55.02 CNY, WuXi AppTec Co Ltd is Undervalued by 60%.

Key Points:
Intrinsic Value
Base Case
135.92 CNY
Undervaluation 60%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
WuXi AppTec Co Ltd

Backtest WuXi AppTec Co Ltd Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling WuXi AppTec Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials

Balance Sheet Decomposition
WuXi AppTec Co Ltd

Current Assets 29.8B
Cash & Short-Term Investments 12.7B
Receivables 9B
Other Current Assets 8.2B
Non-Current Assets 42B
Long-Term Investments 10.1B
PP&E 25.7B
Intangibles 3.8B
Other Non-Current Assets 2.4B
Current Liabilities 17B
Accounts Payable 2.2B
Accrued Liabilities 1.9B
Short-Term Debt 4.6B
Other Current Liabilities 8.3B
Non-Current Liabilities 3.2B
Long-Term Debt 1.4B
Other Non-Current Liabilities 1.8B
Efficiency
Fundamental Scores

Profitability Score
Profitability Due Diligence

WuXi AppTec Co Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Operating Income
Positive Net Income
63/100
Profitability
Score

WuXi AppTec Co Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

WuXi AppTec Co Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Negative Net Debt
77/100
Solvency
Score

WuXi AppTec Co Ltd's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
WuXi AppTec Co Ltd

Wall Street analysts forecast WuXi AppTec Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WuXi AppTec Co Ltd is 122.3 CNY with a low forecast of 81.31 CNY and a high forecast of 176.4 CNY.

Lowest
Price Target
81.31 CNY
48% Upside
Average
Price Target
122.3 CNY
122% Upside
Highest
Price Target
176.4 CNY
221% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
WuXi AppTec Co Ltd

1M 1M
-1%
6M 6M
-31%
1Y 1Y
-34%
3Y 3Y
-55%
5Y 5Y
+47%
10Y 10Y
+325%
Annual Price Range
55.02
52w Low
48.23
52w High
90.88
Price Metrics
Average Annual Return 31.32%
Standard Deviation of Annual Returns 60.05%
Max Drawdown -71%
Shares Statistics
Market Capitalization 163.3B CNY
Shares Outstanding 2 941 172 868
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

WuXi AppTec Co Ltd Logo
WuXi AppTec Co Ltd

Country

China

Industry

Life Sciences Tools & Services

Market Cap

163.3B CNY

Dividend Yield

1.64%

Description

WuXi AppTec Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 34,912 full-time employees. The company went IPO on 2018-05-08. WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The firm is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The firm mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment.

Contact

SHANGHAI
Shanghai
No. 288 Fute Middle Road, Waigaoqiao Free Trade Zone, Pudong New Area
+862120663091.0
https://www.wuxiapptec.com/

IPO

2018-05-08

Employees

34 912

Officers

Co-Founder, Chairman, President & CEO
Dr. Ge Li Ph.D.
Co-CEO & Executive Director
Dr. Qing Yang Ph.D.
Vice Chairman of the Board & Global Chief Investment Officer
Dr. Edward Hu M.B.A.
COO of China, VP & Executive Director
Mr. Zhaohui Zhang
Senior VP & CFO
Ms. Ming Shi
IR Director
Mr. Kyler Lei
Show More
Senior VP, General Counsel & Global Head of Human Resources
Dr. Howard Wu J.D.
Executive Vice President & Head of DDSU
Dr. Shuhui Chen Ph.D.
Senior VP & Head of RCS
Dr. Jingchao Dong Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one WuXi AppTec Co Ltd stock?

The intrinsic value of one WuXi AppTec Co Ltd stock under the Base Case scenario is 135.92 CNY.

Is WuXi AppTec Co Ltd stock undervalued or overvalued?

Compared to the current market price of 55.02 CNY, WuXi AppTec Co Ltd is Undervalued by 60%.